Erste Group flags Central Europe SME scaling as key growth bottleneck, research shows
Bitget2026/10/08 11:32Erste Group research flagged a scaling gap for Central Europe’s 7 million-plus SMEs, despite strong startup formation and rising digital adoption. SMEs account for 99% of regional companies, employ over 20 million people, drive roughly 50%-67% of value added. Poland is the largest market with nearly 2.8 million SMEs, underpinning the region’s entrepreneurial base. Annual business formation runs above the EU average, led by Croatia, Romania, Serbia at over 12% of active firms. Bank lending remains the main external funding source, with limited capital-markets use, constraining cross-border expansion into global leaders. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Erste Group Bank AG published the original content used to generate this news brief on October 08, 2026, and is solely responsible for the information contained therein.
- Erste Group research flagged a scaling gap for Central Europe’s 7 million-plus SMEs, despite strong startup formation and rising digital adoption.
- SMEs account for 99% of regional companies, employ over 20 million people, drive roughly 50%-67% of value added.
- Poland is the largest market with nearly 2.8 million SMEs, underpinning the region’s entrepreneurial base.
- Annual business formation runs above the EU average, led by Croatia, Romania, Serbia at over 12% of active firms.
- Bank lending remains the main external funding source, with limited capital-markets use, constraining cross-border expansion into global leaders.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Canaccord Genuity: Lowers Oklo's target price to $66
"No-drill dental filling" company vVardis (VVVV.US) launches a $214 million US IPO, scheduled to be priced this week.
Dental treatment company vVardis has announced the terms for its $214 million US IPO.
Wegovy improves multiple liver indicators in non-obese liver disease patients, and Novo Nordisk (NVO.US) is expected to expand its market beyond weight loss
Novo Nordisk reports that some patients treated with Wegovy have shown improvements in liver conditions.
Crypto prices
More
